José Luís Lavandera

Author

José Luís Lavandera

Also Known As

Jose L Lavandera, Jose L. Lavandera, Jose Luis LAVANDERA, Jose Luis Lavandera, José L. Lavandera, José L Lavandera, José L. Lavandera, José Luis Lavandera, José Luís Lavandera, Lavandera, Jose

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

GlaxoSmithKline (Spain)Universidad Nacional de Educación a Distancia Universidad San Pablo CEU GlaxoSmithKline (United Kingdom)GlaxoSmithKline (France)

About

José Luís Lavandera is an author at GlaxoSmithKline (Spain) specializing in biochemistry, pharmacology, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Biochemistry	7	7	178
2	Medicine	6	6	195
3	Natural Sciences	6	6	212
4	Engineering	5	5	125
5	Biomedical Engineering	1	1	22

José Luís Lavandera

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
Fueling Open‐Source Drug Discovery: 177 Small‐Molecule Leads against Tuberculosis Lluís Ballell, Robert H. Bates, Rob J. Young, ChemMedChem	2013	308
Identification and Activity of a Series of Azole-based Compounds with Lactate Dehydrogenase-directed Anti-malarial Activity Angus Cameron, Jon Read, R. Tranter, Journal of Biological Chemistry	2004	142
Antitubercular drugs for an old target: GSK693 as a promising InhA direct inhibitor María Martínez-Hoyos, Esther Pérez‐Herrán, Gülçin Gülten, EBioMedicine	2016	81
Translation Elongation Factor 2 Is Part of the Target for a New Family of Antifungals Laura Capa, Alfonso Mendoza, José Luís Lavandera, Antimicrobial Agents and Chemotherapy	1998	79
An Invitation to Open Innovation in Malaria Drug Discovery: 47 Quality Starting Points from the TCAMS Félix Calderón, David Barros, José M. Bueno, ACS Medicinal Chemistry Letters Pharmaceutical ResearchPharmaceutical InnovationHit IdentificationAntiparasitic AgentMalaria	2011	77
Optimization of the Pharmacophore Model for 5-HT<sub>7</sub>R Antagonism. Design and Synthesis of New Naphtholactam and Naphthosultam Derivatives María L. López-Rodrı́guez, Esther Porras, M. J. MORCILLO, Journal of Medicinal Chemistry	2003	70
IGF-I increases markers of osteoblastic activity and reduces bone resorption via osteoprotegerin and RANK-ligand Lucía Guerra-Menéndez, María C. Sádaba, Juan Enrique Puche, Journal of Translational Medicine	2013	64
Mycobacterium tuberculosis Gyrase Inhibitors as a New Class of Antitubercular Drugs Delia Blanco, Esther Pérez‐Herrán, Mónica Cacho, Antimicrobial Agents and Chemotherapy	2015	45
Potent antimalarial 4-pyridones with improved physico-chemical properties José M. Bueno, Pilar Manzano, María C. García, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryAntiparasitic AgentMedicineMalariaPotent Antimalarial 4-Pyridones	2011	40
Alcohol activation by [Ir(COD)(tris(pyrazol-1-yl)methane)]+ and [Ir(COD) (tris(pyrazol-1-yl)ethanel+ cations: formation of alkoxycarbonyl derivatives [(tpzm)IrH(CO2R′)(CO)]+ and [(tpze)IrH(CO2R′)]+ (R′ = Me, Et, i-Pr) Miguel A. Esteruelas, Luis A. Oro, Rosa M. Claramunt, Journal of Organometallic Chemistry Derivative (Chemistry)DerivativesBiochemistryNatural SciencesAlkoxycarbonyl Derivatives	1989	40

Page 1